CVS Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

104.520

Open

103.650

VWAP

103.75

Vol

4.97M

Mkt Cap

130.25B

Low

102.400

Amount

515.33M

EV/EBITDA(TTM)

10.50

Total Shares

1.28B

EV

185.10B

EV/OCF(TTM)

17.92

P/S(TTM)

0.33

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. The Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and, through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.

Show More

Events Timeline

(ET)

2026-07-01

10:30:00

Choice Hotels Appoints CVS Executive Ali Keshavarz to Board

2026-06-23 (ET)

2026-06-23

14:30:00

Florida Attorney General Investigates CVS Health

2026-06-23

11:00:00

Justice Department to Charge 450 Defendants in $6.5B Healthcare Fraud

2026-06-22 (ET)

2026-06-22

08:30:00

CVS Health Launches GLP-1 Support Program

2026-06-17 (ET)

2026-06-17

07:30:00

Western Midstream Partners Launches Second Water Treatment Facility

2026-06-11 (ET)

2026-06-11

07:00:00

UnitedHealth and Others Deny 13% of Medical Requests

News

PRnewswire

07-06PRnewswire

CVS Health to Host Q2 2026 Earnings Call on August 5

Fool

CVS and UnitedHealth Revenue Dynamics

NASDAQ.COM

07-06NASDAQ.COM

Financial Comparison of UnitedHealth and CVS Health

Fool

Vanguard Research Bullish on U.S. Economic Outlook

NASDAQ.COM

07-05NASDAQ.COM

Vanguard Research Bullish on Value Stocks and Bonds

NASDAQ.COM

07-03NASDAQ.COM

Elevance Health Sues CMS Over Medicare Advantage Ratings

17 Analyst Rating

Wall Street analysts forecast CVS stock price to rise

16 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

91.00

Averages

96.71

High

105.00

Current: 0.000

Low

91.00

Averages

96.71

High

105.00

Cantor Fitzgerald

Overweight

maintain

$100 -> $110

AI Analysis

2026-07-07

New

Reason

Cantor Fitzgerald

Price Target

$100 -> $110

AI Analysis

2026-07-07

New

maintain

Overweight

Reason

Cantor Fitzgerald raised the firm's price target on CVS Health to $110 from $100 and keeps an Overweight rating on the shares. Cantor prefers payors over providers heading into Q2 earnings, supported by management discussions, proprietary checks, and investor conversations, the analyst tells investors in a research note. Payors appear better positioned with continued strength in government insurance lines and VBC opportunities, while provider commentary may struggle to meet elevated expectations, limiting upside despite potential guidance increases, the firm says.

HSBC

Hold

maintain

$85 -> $103

2026-07-06

New

Reason

HSBC

Price Target

$85 -> $103

2026-07-06

New

maintain

Hold

Reason

HSBC raised the firm's price target on CVS Health to $103 from $85 and keeps a Hold rating on the shares. In a sector note on Healthcare, HSBC adjusted target prices on the prospects of the sector's relative outperformance potential for the second half of the year, noting that the Therapeutics space offering "attractive risk weighted returns," Tools "might be the best way to play a cyclical rally," and that MedTech is "cheap."

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CVS

Unlock Now

Valuation Metrics

The current forward P/E ratio for CVS Health Corp (CVS.N) is 14.20, compared to its 5-year average forward P/E of 10.40. For a more detailed relative valuation and DCF analysis to assess CVS Health Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

5Y Average PE

10.40

Current PE

14.20

Overvalued PE

11.89

Undervalued PE

8.91

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

5Y Average EV/EBITDA

10.27

Current EV/EBITDA

10.84

Overvalued EV/EBITDA

14.73

Undervalued EV/EBITDA

5.80

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

0.29

Current PS

0.31

Overvalued PS

0.37

Undervalued PS

0.20

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

what stock is pushing the market now

Intellectia · 111 candidates

Market Cap Category: largeRsi Category: moderateRelative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20, PriceAboveMA200Week Price Change Pct: >= $0.00Month Price Change Pct: >= $0.00Is Index Component: GSPC, NDX, DJI

Ticker

Name

Market Cap$

Marvell Technology Inc

173.97B

Thermo Fisher Scientific Inc

169.54B

Gilead Sciences, Inc

165.99B

Corning Inc

164.29B

Honeywell International Inc

146.72B

Salesforce Inc

145.21B

option with low spread for today

Intellectia · 192 candidates

Price: $20.00 - $500.00Market Cap Category: large, midRelative Vol: >= 1Is Optionable: TrueOption Iv Rank: 20 - 60Is Index Component: GSPC, NDX, DJI, RUT

Ticker

Name

Market Cap$

Nextera Energy Inc

194.60B

Walt Disney Co

188.69B

Boeing Co

182.12B

Arista Networks Inc

178.49B

Thermo Fisher Scientific Inc

176.32B

AT&T Inc

175.52B

I need AI to pick a stock and manage it

Intellectia · 2 candidates

Sector: Healthcare, Healthcare Services & Equipment, Pharmaceuticals & Medical ResearchIndustry: Food & Drug Retailing, Healthcare Equipment & Supplies, Healthcare Providers & Services, PharmaceuticalsVolume: >= -100Themes: Medical Instruments & Supplies, Pharmaceutical RetailersRsi Category: moderateMoving Average Relationship: PriceAboveMA5, PriceAboveMA20Monthly Average Dollar Volume: >= -100Macd: positive, bullish

Ticker

Name

Market Cap$

CVS Health Corp

103.78B

Edwards Lifesciences Corp

47.44B

which stocks to buy short term

Intellectia · 40 candidates

Moving Average Relationship: PriceAboveMA20Week Price Change Pct: $4.00 - $12.00Is Index Component: GSPC

Ticker

Name

Market Cap$

Elevance Health Inc

74.87B

Qualcomm Inc

158.82B

Ventas Inc

39.76B

Keurig Dr Pepper Inc

39.76B

Packaging Corp of America

18.95B

Baker Hughes Co

68.37B

today's stock picks

Intellectia · 74 candidates

Volume: >= 1,000,000Price Change Pct: $1.00 - $10.00List Exchange: XNYS, XNASMoving Average Relationship: PriceAboveMA20Is Index Component: GSPC, NDX

Ticker

Name

Market Cap$

Coca-Cola Co

329.83B

Nucor Corp

48.80B

Molina Healthcare Inc

9.17B

Franklin Resources Inc

14.12B

UDR Inc

11.42B

AvalonBay Communities Inc

23.98B

Intellectia · 27 candidates

Market Cap: >= 50.00BDividend Yield Ttm: 2.50 - 6Analyst Consensus: Strong Buy, Moderate BuyBeta: LowRiskRevenue 5yr Cagr: >= 7

Ticker

Name

Market Cap$

Exxon Mobil Corp

618.95B

Chevron Corp

368.92B

Coca-Cola Co

329.83B

UnitedHealth Group Inc

322.34B

Merck & Co Inc

276.38B

Philip Morris International Inc

255.91B

stock of the day

Intellectia · 13 candidates

Market Cap: >= 5.00BPrice Change Pct: >= $3.00Relative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

Avis Budget Group Inc

6.73B

Sasol Ltd

7.96B

UnitedHealth Group Inc

255.38B

Paramount Skydance Corp

10.95B

Humana Inc

21.93B

Applied Optoelectronics Inc

8.35B

money market funds

Intellectia · 68 candidates

Market Cap: >= 1000.00MRegion: USBeta: LowRisk, NegativeBetaList Exchange: XNYS, XNAS, XASEYear Price Change Pct: $2.00 - $8.00Monthly Average Dollar Volume: >= 100,000

Ticker

Name

Market Cap$

Coca-Cola Co

321.48B

Philip Morris International Inc

252.94B

AT&T Inc

201.96B

Chubb Ltd

126.84B

Southern Co

106.81B

Duke Energy Corp

100.69B

best stocks to short

Intellectia · 70 candidates

Market Cap: >= 1000.00MPe Ttm: >= 40List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceBelowMA200Annual Eps Yoy Growth: <= -10.0%Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

Tesla Inc

1.38T

Shopify Inc

152.29B

Palo Alto Networks Inc

132.97B

Capital One Financial Corp

112.86B

Constellation Energy Corp

102.16B

CVS Health Corp

90.94B

which has the highest return?

Intellectia · 14 candidates

Market Cap: >= 5.00BRegion: USPrice: $10.00 - $150.00One Day Rise Prob: >= 60One Day Predict Return: >= 3.0%Monthly Average Dollar Volume: >= 3,000,000

Ticker

Name

Market Cap$

Lincoln National Corp

6.85B

CVS Health Corp

96.93B

Red Rock Resorts Inc

6.46B

Pinterest Inc

11.69B

Manulife Financial Corp

59.36B

Qiagen NV

10.06B

Whales Holding CVS

Mubadala Investment Company PJSC

Maple Rock Capital Partners Inc.

Epoch Investment Partners, Inc.

Glenview Capital Management, LLC

Turtle Creek Management, LLC

Letko, Brosseau & Associates Inc.

Trading Trends

People Also Watch

Frequently Asked Questions

What is CVS Health Corp (CVS) stock price today?

The current price of CVS is 104.33 USD — it has increased 2.2

What is CVS Health Corp (CVS)'s business?

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. The Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and, through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.

What is the price predicton of CVS Stock?

Wall Street analysts forecast CVS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CVS is96.71 USD with a low forecast of 91.00 USD and a high forecast of 105.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is CVS Health Corp (CVS)'s revenue for the last quarter?

CVS Health Corp revenue for the last quarter amounts to 100.43B USD, increased 6.17

What is CVS Health Corp (CVS)'s earnings per share (EPS) for the last quarter?

CVS Health Corp. EPS for the last quarter amounts to 2.30 USD, increased 63.12

How many employees does CVS Health Corp (CVS). have?

CVS Health Corp (CVS) has 300000 emplpoyees as of July 07 2026.

What is CVS Health Corp (CVS) market cap?

Today CVS has the market capitalization of 130.25B USD.